Werdegang
Aktuelle Positionen:
| 2022 | Medical Co-Director (ad interim), University Hospital Zurich |
|---|---|
| seit 2004 | Chairman, Department of Pathology and Molecular Pathology, University Hospital Zurich, Switzerland |
| seit 2004 | Full Professor of Pathology, University Zurich, Switzerland |
Ausbildung und akademische Erfahrung:
| 2008 – 2021 | Chairman, Operational Division of Medical Diagnostics, University Hospital Zurich, Switzerland |
|---|---|
| 08./09.2001 | Visiting Fellow. Harvard Medical School, Department of Pathology, Massachusetts General Hospital Boston, Massachusetts, USA |
| 1995 – 2008 | Staff (Oberarzt, Leitender Arzt); Institute of Pathology, University Hospital Basel, Switzerland |
| 1994 | Research Fellow; Division of Molecular Cytometry, Department of Laboratory Medicine, University of California San Francisco; San Francisco; USA |
| 1990 – 1993 | Pathology Resident; Institute of Pathology, University Hospital Basel; Switzerland |
| 1988 – 1990 | Pathology Resident, Institute of Pathology, Charité, Berlin, Germany |
Mitgliedschaften
Mitgliedschaften:
| 2018 | WHO Classification of Tumours; 5th Edition. Editorial Board Standing Member |
|---|---|
| 2015 | Member of the Swiss Academy of Medical Sciences |
| 2007 | Member of the German Academy of Science “Leopoldina” |
Mitgliedschaften in wissenschaftlichen Beiräten und akademischen Ausschüssen:
| seit 2021 | International Collaboration of Cancer Reporting, Board of Directors |
|---|---|
| seit 2021 | Comprehensive Cancer Center Freiburg (CCCF); Scientific Advisory Board |
| seit 2020 | Comprehensive Cancer Center Zurich (CCCZ), Executive Committee |
| seit 2017 | Charles Rodolphe Brupbacher Foundation for Cancer Research; Foundation Board and Scientific Advisory Board |
| seit 2016 | Interdisciplinary Center for Clinical Research (IZKF) of the Friedrich- Alexander University Erlangen-Nürnberg (FAU); Scientific Advisory Board |
| seit 2004 | Cancer Registry of the Cantons Zurich, Zug, Schaffhausen, Schwyz; Executive Committee |
| 2021 | Immediate Past President of the European Society of Pathology |
| 2019 – 2020 | President of the European Society of Pathology (ESP) |
| 2018 – 2020 | Cancer Research Center Zurich, Executive Committee |
| 2018, 2021 | German Cancer Consortium (DKTK) of the German Cancer Research Center (DKFZ) Heidelberg; Scientific Advisory Board |
| 2009-2017 | German Society of Pathology (DGP); Secretary/Treasurer |
| 2010, 2012 | Charité Comprehensive Cancer Center; Scientific Advisory Board |
| 2006 – 2009 | Charles Rodolphe Brupbacher Foundation for Cancer Research; Scientific Advisory Board |
| 2005 – 2014 | Krebsforschung Schweiz; Scientific Committee (WiKo) |
| 2004 – 2010 | Swiss Group for Clinical Cancer Research (SAKK); Executive Committee |
| 2004 – 2010 | Swiss Society of Pathology (SGPath), Executive Committee |
Patente
- 08716518.9-2406 „Monoclonal human tumor-specific antibody“ (21.10.2009)
- 08716519.7-2406 „Method of providing human tumor-specific antibodies“ (16.10.2009)
- 10162783.4-2201 „Discrete states for use as biomarkers“ (5.7.2010)
Organisation von Konferenzen
| 2021 | 33rd European Congress of Pathology |
|---|---|
| 2020 | 32rd European Congress of Pathology |
| 2015 | WHO-Symposium “Recent Advances in Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs” |
| 2012 | WHO-Symposium “Recent Advances in the Pathology and Genetics of Soft Tissue and Bone Tumors” |
| 2012 | Leopoldina-Symposium “Autopsie und Religion” |
| 2009 | Charles Rodolphe Brupbacher Symposium |
| 2007 | Charles Rodolphe Brupbacher Symposium |